Efficacy of Surgicel® (Fibrillar) for preventing bleeding after endoscopic submucosal dissection for gastric epithelial tumors.
Jae Jin HwangSu Jin HongJae Pil HanBong Min KoTae Hee LeeJoon Seong LeePublished in: Journal of digestive diseases (2018)
Combination therapy with Surgicel and an H2 RA decreased the rate of bleeding similarly to PPI. Adding Surgicel to H2 RA could be considered for patients with bleeding tendencies, or who require continuous antiplatelet therapy to prevent bleeding after ESD.